Aeglea BioTherapeutics, Inc. 4
4 · Aeglea BioTherapeutics, Inc. · Filed Mar 22, 2017
Insider Transaction Report
Form 4
Rowlinson Scott W
VP, Research
Transactions
- Award
Employee Stock Option (right to buy)
2017-03-20+60,000→ 60,000 totalExercise: $8.03Exp: 2027-03-19→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on April 20, 2017, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.